May 152020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NY – Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today the appointment of Judith Dunn, Ph.D. to its Board of Directors. “It's our privilege and honor to have Judy on our ...

Seelos Therapeutics appoints Dr Judith Dunn to its Board of Directors

Seelos Therapeutics appoints Dr Judith Dunn to its Board of Directors

From:: Seelos Therapeutics appoints Dr Judith Dunn to its Board of Directors

Sorry, the comment form is closed at this time.